Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Depreciation & Amortization - Total (2009 - 2011)

Updated

Vistagen Therapeutics' Depreciation & Amortization - Total was $892.00 in FY2010 (year ended Dec 31, 2010), up 108.4% from $428.00 in FY2009.

Analysis

Vistagen Therapeutics (VTGN) Depreciation & Amortization - Total (2009 - 2011) Analysis & Trends

  • Per Business Quant data, Depreciation & Amortization - Total in earlier fiscal years was $428.00 in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn -
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn -
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn -
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn -
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn -
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2011 999.00
Dec 31, 2010 571.00
Sep 30, 2010 785.00
Jun 30, 2010 678.00
Mar 31, 2010 107.00
Dec 31, 2009 107.00
Sep 30, 2009 107.00
Jun 30, 2009 107.00
Mar 31, 2009 107.00
API Access

Vistagen Therapeutics Depreciation & Amortization - Total API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-total&ticker=VTGN&period=max&api_key=YOUR_API_KEY